to acquire full ownership of the U.S.-based biopharmaceutical company, best known for its Palforzia treatment for peanut allergies. Nestle already had a 25.6% stake in Aimmune, and will pay $34.
50 per share for the remainder compared to Aimmune's Friday closing price of $12.60. – JPMorgan Chase analyst Stephen Tusa removed his price target on GE, citing the lack of forward visibility. The firm's rating on GE remains at "neutral," although the report said the fair value of the stock is likely less than $5 per share.
The Democratic Party has become the party of intolerance, censorship and Racism. Democrats have incited riots and promoted Marxist revolution, but offered NO protection to law abiding citizens. The country is waking to their evil and it has sealed their fate!